Table 1.
Demographic characteristics of treated patients
| Placebo (n=212) | Nitazoxanide 300 mg (n=201) | Nitazoxanide 600 mg (n=211) | |
|---|---|---|---|
| Ethnic origin | |||
| White | 140 (66%) | 120 (60%) | 138 (65%) |
| Black | 40 (19%) | 46 (23%) | 37 (18%) |
| Hispanic | 23 (11%) | 29 (14%) | 29 (14%) |
| Other | 9 (4%) | 6 (3%) | 7 (3%) |
| Sex | |||
| Male | 90 (43%) | 97 (48%) | 82 (39%) |
| Age (years) | |||
| Mean (SD) | 34·3 (13·3) | 32·5 (12·6) | 34·7 (13·2) |
| Range | 12–67 | 12–63 | 12–66 |
| Smoker | |||
| Yes | 37 (18%) | 30 (15%) | 25 (11%) |
| Weight (kg) | |||
| Mean (SD) | 84·7 (25·2) | 84·1 (23·7) | 83·9 (22·8) |
| Range | 40–186 | 44–167 | 39–163 |
| BMI (kg/m2) | |||
| Mean (SD) | 29·8 (7·8) | 28·8 (7·1) | 29·6 (7·9) |
| Range | 17·3–57·2 | 16·6–54·5 | 13·9–59·2 |
Data are n (%) unless otherwise indicated. BMI=body-mass index.